This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Medlmmune Limited, University of California. Active years: 2021.
Company Filing History:
1 out of 6 
1 out of 15,977 
Years Active: 2021
Title: The Innovative Contributions of Andrew Csordas
Introduction
Andrew Csordas is a notable inventor based in Santa Barbara, CA. He has made significant contributions to the field of biotechnology, particularly in the detection of residual host cell proteins in recombinant protein preparations. His work has implications for improving the quality and safety of biopharmaceuticals.
Latest Patents
Andrew Csordas holds a patent for a method of detecting residual host cell proteins (HCPs) in recombinant protein preparations. This patent outlines a method that utilizes aptamers to identify the presence of HCPs. The process involves providing a recombinant protein preparation, creating a final pool of aptamers, and combining these elements to determine the presence or absence of multiple HCPs.
Career Highlights
Throughout his career, Andrew has worked with prominent organizations such as MedImmune Limited and the University of California. His experience in these institutions has allowed him to develop innovative solutions in the biotechnology sector.
Collaborations
Andrew has collaborated with notable colleagues, including Faye Walker and Robert Strouse. These partnerships have contributed to his research and development efforts in the field.
Conclusion
Andrew Csordas is a distinguished inventor whose work in detecting residual host cell proteins has advanced the biotechnology industry. His contributions continue to influence the development of safer and more effective biopharmaceuticals.